Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors

Jin San Zhang, Matthew Nelson, Bryan McIver, Ian D Hay, John R. Goellner, Clive S. Grant, Norman L. Eberhardt, David I Smith

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We analysed 42 differentiated thyroid tumors including 15 follicular adenomas (FA), 13 papillary thyroid cancers (PTC) and 14 follicular thyroid carcinomas (FTC) with 13 microsatellite markers specific for the long arm of human chromosome 7 within 7q31; this region is deleted frequently in several other tumor types. Overall, 20 of the 42 samples analysed (48%) displayed LOH with one or more of the markers tested. LOH was detected most frequently (78%) in FTC, the most malignant of the thyroid tumors. A smallest common deleted region (SCDR) was defined in this tumor type flanked by markers D7S480 and D7S490. This SCDR is distinct from D7S522, the most commonly deleted locus in many other tumors, which was deleted in only one FTC. D7S522 did show LOH in two of six informative PTCs. None of the PTC and only two of the FAs showed LOH in the FTC SCDR. Since FA is considered a premalignant stage of FTC, our results suggest that inactivation of a putative tumor suppressor at 7q31.2 may be acquired during adenoma to carcinoma progression. The absence of LOH at this locus amongst PTC suggests that inactivation of this tumor suppressor is specific for FTC. In conclusion, LOH at 7q31 is a frequent event in differentiated thyroid cancer, and we have defined a 2 cM SCDR specific for FTC.

Original languageEnglish (US)
Pages (from-to)789-793
Number of pages5
JournalOncogene
Volume17
Issue number6
StatePublished - Aug 13 1998

Fingerprint

Follicular Adenocarcinoma
Loss of Heterozygosity
Thyroid Gland
Neoplasms
Adenoma
Factor IX
Chromosomes, Human, Pair 7
Human Chromosomes
Tumor Biomarkers
Thyroid Neoplasms
Microsatellite Repeats
Carcinoma

Keywords

  • 7q31.23
  • FRA7G
  • LOH
  • Thyroid cancer

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Zhang, J. S., Nelson, M., McIver, B., Hay, I. D., Goellner, J. R., Grant, C. S., ... Smith, D. I. (1998). Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene, 17(6), 789-793.

Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. / Zhang, Jin San; Nelson, Matthew; McIver, Bryan; Hay, Ian D; Goellner, John R.; Grant, Clive S.; Eberhardt, Norman L.; Smith, David I.

In: Oncogene, Vol. 17, No. 6, 13.08.1998, p. 789-793.

Research output: Contribution to journalArticle

Zhang, JS, Nelson, M, McIver, B, Hay, ID, Goellner, JR, Grant, CS, Eberhardt, NL & Smith, DI 1998, 'Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors', Oncogene, vol. 17, no. 6, pp. 789-793.
Zhang JS, Nelson M, McIver B, Hay ID, Goellner JR, Grant CS et al. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene. 1998 Aug 13;17(6):789-793.
Zhang, Jin San ; Nelson, Matthew ; McIver, Bryan ; Hay, Ian D ; Goellner, John R. ; Grant, Clive S. ; Eberhardt, Norman L. ; Smith, David I. / Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. In: Oncogene. 1998 ; Vol. 17, No. 6. pp. 789-793.
@article{d22a0b21cc9d4bc9a48545acc8680fa5,
title = "Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors",
abstract = "We analysed 42 differentiated thyroid tumors including 15 follicular adenomas (FA), 13 papillary thyroid cancers (PTC) and 14 follicular thyroid carcinomas (FTC) with 13 microsatellite markers specific for the long arm of human chromosome 7 within 7q31; this region is deleted frequently in several other tumor types. Overall, 20 of the 42 samples analysed (48{\%}) displayed LOH with one or more of the markers tested. LOH was detected most frequently (78{\%}) in FTC, the most malignant of the thyroid tumors. A smallest common deleted region (SCDR) was defined in this tumor type flanked by markers D7S480 and D7S490. This SCDR is distinct from D7S522, the most commonly deleted locus in many other tumors, which was deleted in only one FTC. D7S522 did show LOH in two of six informative PTCs. None of the PTC and only two of the FAs showed LOH in the FTC SCDR. Since FA is considered a premalignant stage of FTC, our results suggest that inactivation of a putative tumor suppressor at 7q31.2 may be acquired during adenoma to carcinoma progression. The absence of LOH at this locus amongst PTC suggests that inactivation of this tumor suppressor is specific for FTC. In conclusion, LOH at 7q31 is a frequent event in differentiated thyroid cancer, and we have defined a 2 cM SCDR specific for FTC.",
keywords = "7q31.23, FRA7G, LOH, Thyroid cancer",
author = "Zhang, {Jin San} and Matthew Nelson and Bryan McIver and Hay, {Ian D} and Goellner, {John R.} and Grant, {Clive S.} and Eberhardt, {Norman L.} and Smith, {David I}",
year = "1998",
month = "8",
day = "13",
language = "English (US)",
volume = "17",
pages = "789--793",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors

AU - Zhang, Jin San

AU - Nelson, Matthew

AU - McIver, Bryan

AU - Hay, Ian D

AU - Goellner, John R.

AU - Grant, Clive S.

AU - Eberhardt, Norman L.

AU - Smith, David I

PY - 1998/8/13

Y1 - 1998/8/13

N2 - We analysed 42 differentiated thyroid tumors including 15 follicular adenomas (FA), 13 papillary thyroid cancers (PTC) and 14 follicular thyroid carcinomas (FTC) with 13 microsatellite markers specific for the long arm of human chromosome 7 within 7q31; this region is deleted frequently in several other tumor types. Overall, 20 of the 42 samples analysed (48%) displayed LOH with one or more of the markers tested. LOH was detected most frequently (78%) in FTC, the most malignant of the thyroid tumors. A smallest common deleted region (SCDR) was defined in this tumor type flanked by markers D7S480 and D7S490. This SCDR is distinct from D7S522, the most commonly deleted locus in many other tumors, which was deleted in only one FTC. D7S522 did show LOH in two of six informative PTCs. None of the PTC and only two of the FAs showed LOH in the FTC SCDR. Since FA is considered a premalignant stage of FTC, our results suggest that inactivation of a putative tumor suppressor at 7q31.2 may be acquired during adenoma to carcinoma progression. The absence of LOH at this locus amongst PTC suggests that inactivation of this tumor suppressor is specific for FTC. In conclusion, LOH at 7q31 is a frequent event in differentiated thyroid cancer, and we have defined a 2 cM SCDR specific for FTC.

AB - We analysed 42 differentiated thyroid tumors including 15 follicular adenomas (FA), 13 papillary thyroid cancers (PTC) and 14 follicular thyroid carcinomas (FTC) with 13 microsatellite markers specific for the long arm of human chromosome 7 within 7q31; this region is deleted frequently in several other tumor types. Overall, 20 of the 42 samples analysed (48%) displayed LOH with one or more of the markers tested. LOH was detected most frequently (78%) in FTC, the most malignant of the thyroid tumors. A smallest common deleted region (SCDR) was defined in this tumor type flanked by markers D7S480 and D7S490. This SCDR is distinct from D7S522, the most commonly deleted locus in many other tumors, which was deleted in only one FTC. D7S522 did show LOH in two of six informative PTCs. None of the PTC and only two of the FAs showed LOH in the FTC SCDR. Since FA is considered a premalignant stage of FTC, our results suggest that inactivation of a putative tumor suppressor at 7q31.2 may be acquired during adenoma to carcinoma progression. The absence of LOH at this locus amongst PTC suggests that inactivation of this tumor suppressor is specific for FTC. In conclusion, LOH at 7q31 is a frequent event in differentiated thyroid cancer, and we have defined a 2 cM SCDR specific for FTC.

KW - 7q31.23

KW - FRA7G

KW - LOH

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=0032514375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032514375&partnerID=8YFLogxK

M3 - Article

C2 - 9715281

AN - SCOPUS:0032514375

VL - 17

SP - 789

EP - 793

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 6

ER -